Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS)

Clinical trial NCT00101985 · COMPLETED

Trial details

NCT number: NCT00101985
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Irritable Colon

Start date: 2004-10-01
Primary completion: 2005-07-01
Enrollment: 741

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.